EpiBiologics, Inc. is a biotechnology company headquartered in San Mateo, California, focused on drug pipelines and therapeutic developments.
Subscribe to see EpiBiologics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EpiBiologics, Inc. is a drug discovery company headquartered in United States. It has raised at least $310M across the 4 funding rounds on record. Its most recent funding round, Series B, raised $107M in January 2026. Xcout tracks 7 named people at EpiBiologics, Inc., including Ann Lee-Karlon (Chief Executive Officer and President).
1 more named person on record for EpiBiologics, Inc., with roles, board committees and tenure — see the full roster →
At least $310M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $107M | — | |
| Series B | $107M | 8 named | |
| Series B | $50M | 13 named | |
| SEC Form D filing | $73M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of EpiBiologics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
BRC Therapeutics is a pharmaceutical company headquartered in Castroville, California. The company focuses on developing proprietary cannabinoid therapeutics and innovative treatments to provide relief from pain and neurological conditions.
Artielle Immunotherapeutics is a venture-backed, clinical-stage biotechnology company pioneering novel therapeutics. It maintains its headquarters in Portland, Oregon, with additional presence in San Mateo, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.